Harvard Management Company Renews Facebook Investments, Buys Gambling and Tech Stocks As Securities Value Spikes in Third Quarter
Harvard Law School Lecturer and Alum Ronald A. Klain Named Biden’s Chief of Staff
Amid Ivy League Cancellations, Most Varsity Sports Teams See Marked Decrease in Roster Size
Harvard Forward, Fresh Off of Board of Overseers Wins, Sets Sights on 2021 With New Slate of Candidates
‘Frivolous,’ ‘Insubstantial,’ ‘Bad Faith’: Harvard Law Experts Weigh In On Trump Election Lawsuits
President-elect Joseph R. Biden Jr.’s transition team named an advisory board of 13 public health and scientific experts on Monday to advise the next administration’s COVID-19 response.
“Dealing with the coronavirus pandemic is one of the most important battles our administration will face, and I will be informed by science and by experts,” Biden said in the press release. “The advisory board will help shape my approach to managing the surge in reported infections; ensuring vaccines are safe, effective, and distributed efficiently, equitably, and free; and protecting at-risk populations.”
The committee will be co-chaired by former Food and Drug Administration commissioner David A. Kessler, Yale University Associate Dean for Health Equity Research Marcella Nunez-Smith, and former U.S. Surgeon General Vivek H. Murthy ’98.
Kessler, a Harvard Medical School alumnus, served as FDA commissioner under George W. Bush and William J. Clinton and was the dean of two schools of public health.
Nunez-Smith, who completed her residency training at Harvard Medical School-affiliated Brigham and Women’s Hospital, said she and the rest of the board would focus on recovery for all Americans, including communities of color facing a “disproportionate” burden.
"Our country is facing an unprecedented time with COVID-19 cases accelerating nationwide. Everyone is affected by this pandemic, yet the burden is disproportionate. We know communities of color are grieving at high rates and are facing substantial economic impact,” Nunez-Smith wrote in an emailed statement. “The transition advisory board is setting a course for everyone in our country to experience recovery.”
Murthy was an attending physician and instructor in medicine at Brigham and Women’s Hospital before his confirmation as surgeon general during Barack Obama’s second term.
The board also includes Rick A. Bright, the former director of the Biomedical Advanced Research and Development Authority. Bright was ousted from his role after he filed a whistleblower complaint against the U.S. Department of Health and Human Services alleging his early warnings about the pandemic were ignored by the Trump administration.
Harvard Medical School and School of Public Health Professor Atul A. Gawande, a Medical School alumnus who was also tapped for the committee, wrote in a statement that he believes the virus can be contained, despite the current “runaway spread.”
"We have runaway spread right now,” Gawande wrote. “But I am confident we can get the virus under control, save lives and livelihoods, and bring people back together again.”
Other committee members with Harvard ties include Medical School alumni Ezekiel J. Emanuel, a former Obama administration health policy advisor, and Robert M. Rodriguez, professor of emergency medicine at University of California at San Francisco. Celine R. Gounder, an assistant professor at NYU Grossman School of Medicine, completed her residency training in internal medicine at Massachusetts General Hospital, the Medical School's largest teaching hospital.
Biden’s advisory board also includes former assistant FDA commissioner Luciana Borio, former Chicago public health commissioner Julie Morita, Executive Director of the Global Health Council Loyce Pace, Director of the Center for Infectious Disease Research and Policy at the University of Minnesota Michael T. Osterholm, and former U.S. Global AIDS Coordinator Eric P. Goosby.
—Staff writer Virginia L. Ma can be reached at firstname.lastname@example.org.
Want to keep up with breaking news? Subscribe to our email newsletter.